Last updated on April 18, 2014 at 8:55 EDT

Latest Listing Rules Stories

2012-10-08 23:20:28

ZURICH, Oct. 9, 2012 /PRNewswire/ -- Cytos Biotechnology Ltd ("Cytos" or "the Company"), a Swiss biotech company focused on the development of CYT003 in allergic asthma, announced today the appointment of Dr. Christian Itin as Chief Executive Officer. As announced on 29 May 2012, the Board will propose to the Company's shareholders that Dr. Itin be elected as member of the Board, and it is intended that he will succeed Dr. Thomas Hecht as Chairman of the Board of Directors as of an...